Segulah IV L.P. has acquired two leaders in skin care, dental care and disinfection: CCS, which was earlier owned by Segulah II, L.P., and Opus Health Care.
“CCS is returning to the Segulah family. The combination with Opus Health Care will create a new player with a stronger product range and broader customer base. This puts us in an excellent position to develop further as a strong supplier and value-added partner to our customers through continued product development and geographical expansion,”says Jonas Nilsson, CEO of CCS.
“We and CCS have both been owned by groups where we were outside the core business. Now we will be an independent, focused group with an owner willing to invest and seeking expansion,” says Thomas Rappe, Commercial Director at Opus Health Care.
CCS is one of Sweden’s leading producers and distributors of personal care products in skin and dental care, pharmaceutical products in skin and eye care, and gastroenterology, and is a supplier and partner primarily to pharmacies in Sweden, the rest of the Nordic region and the UK. CCS is focused on product development and has a strong product portfolio with brands such as CCS, Oliva by CCS and Vera by CCS. It has also developed products in collaboration with other brand owners such as Bamse and Odd Molly. Production, which includes contract manufacturing, is located in Borlänge, Sweden.
Learn more about CCS at www.byccs.com. The seller is the privately held US consumer products company that acquired CCS from Segulah II, L.P. in 2005.
Opus Health Care is a market leader in Swedish health care with a variety of disinfectant and skin care products marketed to hospitals and public health care providers, office supply wholesalers and others in the Nordic region. Its most important brand is DAX, comprising a line of disinfectant, skin care and skin wash products. In collaboration with Unilever, Opus Health Care also markets Zendium dental care products and Neutral, a line of ecolabeled washing, detergent and hygiene products free of perfumes and unnecessary chemical additives.
Learn more about Opus Health Care: www.opushc.se. Seller is Unilever.
For further information visit www.segulah.se or contact:
Christian Sievert, Managing Partner, Segulah Advisor AB
Cell: +46 (0)708 66 96 94, email@example.com
Christian Tegenmark, Investment Manager, Segulah Advisor AB
Cell: +46 (0)707 67 12 92, firstname.lastname@example.org
Jonas Nilsson, CEO, CCS, Cell: +46 (0)705 54 16 80
Thomas Rappe, Commercial Director, Opus Health Care,
Cell +46 (0)705 87 30 59, email@example.com